AI

Pharma: Novo Nordisk's Wegovy pill launch significantly increases patient interest in GLP-1 weight loss treatments.

Apr 7, 2026 - 11:40
 0  0
Pharma: Novo Nordisk's Wegovy pill launch significantly increases patient interest in GLP-1 weight loss treatments.
CNBC caught up with five U.S. patients who recently began taking the new pill after its launch. They each shared their unique initial experiences with the medication. Check out their stories! #HealthNews #PatientStories

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0

Related Posts

I took my 30-year-old son on a vacation to Hawaii. We had to set ground rules first.

I took my 30-year-old son on a vacation to Hawaii. We h...

Jun 21, 2026  0  0

U.S. and Iran negotiators begin talks in Switzerland amid rising Strait of Hormuz tensions

U.S. and Iran negotiators begin talks in Switzerland am...

Jun 21, 2026  0  0

She saved $24,000 to launch a craft festival in an old Joann store: 'This is my dream come true'

She saved $24,000 to launch a craft festival in an old ...

Jun 21, 2026  0  0

Tech workers are spending nights and weekends learning new AI tools. They say they can't afford not to.

Tech workers are spending nights and weekends learning ...

Jun 21, 2026  0  0

Weight loss without muscle loss? The next generation of drugs is testing the idea

Weight loss without muscle loss? The next generation of...

Jun 21, 2026  0  0

The FIRE movement is burning up, but is it actually worth it?

The FIRE movement is burning up, but is it actually wor...

Jun 21, 2026  0  0